Middle Branch Partners advised KMM Group during an investment from RS2 Healthcare Partners

Middle Branch Partners advised KMM Group Ltd. as they sought and received a significant investment from RS2 Healthcare Partners, a private equity firm in Boston, MA.

From KMM’s press release:

“KMM Group (“KMM” or the “Company”), a vertically integrated precision contract manufacturer specializing in complex, tight-tolerance components for the medical device industry and other highly demanding markets, today announced the completion of an investment by RS2 Healthcare Partners (“RS2”), a Boston-based private equity firm.

In conjunction with the investment, KMM announced the appointment of J. Mark King as President and Chief Executive Officer. Co-founder John Shegda will serve as Chief Technology Officer, leading engineering and technology strategy, while Co-founder Eric Wilhelm has been appointed Executive Vice President, Business Transformation & Organizational Capability, overseeing operational excellence and scalable growth. The leadership changes preserve continuity for customers, employees, and partners and position the Company for continued growth and manufacturing excellence.

‘KMM has earned customers’ trust by solving complex manufacturing challenges that many others simply cannot do,’ said J. Mark King. ‘I am honored and excited to continue building on KMM’s momentum. I have a long history of working with the principals at RS2 Healthcare Partners as well as serving as an advisor to KMM. With this investment, I look forward to partnering with RS2, John, Eric and the rest of the KMM team to expand the Company’s capabilities and further strengthen its position as a premier contract manufacturer for medtech and other end markets.’”